- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 44.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 43.99M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 19.67M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.96M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.67M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $13.21M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $15.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $3.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $22.43M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $24.9M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.49M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.05M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.91M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $18.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $20.14M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $26.34M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $28.39M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.13 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $47.32K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $78.13K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $83.26K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $255.48K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.27M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.65M |